InsidersTradesSigma
Declaraciones totales
Empresa
▲ Compras (0 oper.)
▼ Ventas (10 oper.)
Historial del iniciado
Director GeneralCompras declaradas
0
Ventas declaradas
10
Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the full record of transactions filed by Gano Kyle, Director General. Insider active across 1 company, notably Neurocrine Biosciences INC. In total, 20 filings have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €1.2m. History available since 5 January 2022. The latest transaction was disclosed on 12 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Gano Kyle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones20 en total
20 de 20 declaraciones
About Gano Kyle
Kyle Gano serves as Chief Executive Officer and Chief Business Development Officer at Neurocrine Biosciences Inc. He leads the company's strategic initiatives and oversees the development of new business opportunities. Kyle brings expertise in management and product development, contributing to innovation and growth at Neurocrine.
